AAAAAA

   
Results: 1-8 |
Results: 8
Extragonadal seminoma after renal transplantation and immunosuppression; Treatment in the presence of renal dysfunction - A case report and literature review
Authors: Kosmas, C Tsavaris, NB Vadiaka, M Chiras, T Boletis, J Kostakis, A
Citation: C. Kosmas et al., Extragonadal seminoma after renal transplantation and immunosuppression; Treatment in the presence of renal dysfunction - A case report and literature review, MED ONCOL, 18(3), 2001, pp. 221-225
Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane plus platinum-based regimens
Authors: Kosmas, C Tsavaris, N Panopoulos, C Vadiaka, M Stavroyianni, N Kourelis, T Malamos, N Antonopoulos, M Kalofonos, HP
Citation: C. Kosmas et al., Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane plus platinum-based regimens, EUR J CANC, 37(8), 2001, pp. 972-978
Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer
Authors: Kosmas, C Tsavaris, NB Malamos, NA Vadiaka, M Koufos, C
Citation: C. Kosmas et al., Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer, J CL ONCOL, 19(1), 2001, pp. 119-126
Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study
Authors: Tsavaris, N Kosmas, C Vadiaka, M Kontos, A Katsorida, M Dimitrakopoulos, A Zerai, A Koufos, C
Citation: N. Tsavaris et al., Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study, J EXP CL C, 20(1), 2001, pp. 29-34
Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens
Authors: Kosmas, C Tsavaris, N Vadiaka, M Stavroyianni, N Koutras, A Malamos, N Onyenadum, A Rokana, S Polyzos, A Kalofonos, HP
Citation: C. Kosmas et al., Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens, CANCER, 92(11), 2001, pp. 2902-2910
Combined treatment with low-dose interferon plus vinblastine is associatedwith less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma
Authors: Tsavaris, N Skarlos, D Bacoyiannis, C Aravantinos, G Kosmas, C Retalis, G Panopoulos, C Vadiaka, M Dimitrakopoulos, A Kostantinidis, K Mitropoulos, D Bougas, D Pantazopoulos, D Kosmidis, P
Citation: N. Tsavaris et al., Combined treatment with low-dose interferon plus vinblastine is associatedwith less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma, J INTERF CY, 20(8), 2000, pp. 685-690
Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy
Authors: Tsavaris, N Kosmas, C Mylonakis, N Bacoyiannis, C Kalergis, G Vadiaka, M Boulamatsis, D Iakovidis, V Kosmidis, P
Citation: N. Tsavaris et al., Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy, ANTICANC R, 20(6C), 2000, pp. 4777-4783
A Phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma
Authors: Kosmas, C Tsavaris, NB Polyzos, A Kalofonos, HP Sepsas, E Malamos, NA Vadiaka, M Dosios, T Antonopoulos, MJ
Citation: C. Kosmas et al., A Phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma, CANCER, 89(4), 2000, pp. 774-782
Risultati: 1-8 |